DelSiTech Ltd (infodelsitech.com), Nov 18th 2016
DelSiTech and MedImmune, the global biologics research and development of AstraZeneca, presented yesterday a joint poster at this year’s American Association of Pharmaceutical Scientists (AAPS) meeting in Denver, Colorado (November 13-17). The poster, number 17R1130, is entitled “Silica Microparticles for Sustained Delivery of MR1 Antibody”. DelSiTech’s biodegradable silica based drug delivery technology continues to demonstrate its capabilities in the formulation and delivery of biologicals and the data presented at AAPS further supports such continuing activities. The poster showed in vivo sustained release of a model antibody with zero order release.